A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Müllenbach, Roman ^a   Weber, Susanne N ^a   Krawczyk, Marcin ^a   Zimmer, Vincent ^a   Sarrazin, Christoph ^b   Lammert, Frank ^a   Grünhage, Frank ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BILE SALT; BILE SALT EXPORT PUMP; UNCLASSIFIED DRUG;

ABCB11 GENE; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GERMANY; HEPATITIS C; HEPATOBILIARY PARAMETERS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFECTION RISK; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; DISEASE PROGRESSION; ELASTICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GERMANY; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84861920061     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-63     Document Type: Article

References (40)

1. Offergeld R, Ritter S, Quabeck L, Hamouda O. Epidemiological data on infections among blood donors in Germany 2007. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010, 53(11):1188-1196. 10.1007/s00103-010-1152-6, 20976426.
2. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, Nawrocki M, Kruska L, Hensel F, Petry W, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998, 28(6):1687-1695. 10.1002/hep.510280632, 9828236.
3. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002, 36(5 Suppl 1):S35-S46.
4. Sheehan MM, Doyle CT, Whelton M, Kenny-Walsh E. Hepatitis C virus liver disease in women infected with contaminated anti-D immunoglobulin. Histopathology 1997, 30(6):512-517. 10.1046/j.1365-2559.1997.5530803.x, 9205854.
5. Fanning LJ. The Irish paradigm on the natural progression of hepatitis C virus infection: an investigation in a homogeneous patient population infected with HCV 1b (review). Int J Mol Med 2002, 9(2):179-184.
6. Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK. Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol 2004, 72(1):60-65. 10.1002/jmv.10533, 14635012.
7. Hohler T, Kruger A, Gerken G, Schneider PM, Büschenfelde KH MZ, Rittner C. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol 1998, 54(3):173-177. 10.1002/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2, 9515764.
8. Rosen HR, McHutchison JG, Conrad AJ, Lentz JJ, Marousek G, Rose SL, Zaman A, Taylor K, Chou S. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol 2002, 97(3):714-720. 10.1111/j.1572-0241.2002.05552.x, 11922568.
9. Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 2001, 33(3):708-712. 10.1053/jhep.2001.22347, 11230752.
10. Bosi I, Ancora G, Mantovani W, Miniero R, Verucchi G, Attard L, Venturi V, Papa I, Sandri F, Dallacasa P, et al. HLA DR13 and HCV vertical infection. Pediatr Res 2002, 51(6):746-749. 10.1203/00006450-200206000-00014, 12032271.
11. Vejbaesya S, Songsivilai S, Tanwandee T, Rachaibun S, Chantangpol R, Dharakul T. HLA association with hepatitis C virus infection. Hum Immunol 2000, 61(3):348-353. 10.1016/S0198-8859(99)00131-7, 10689128.
12. Zavaglia C, Martinetti M, Silini E, Bottelli R, Daielli C, Asti M, Airoldi A, Salvaneschi L, Mondelli MU, Ideo G. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 1998, 28(1):1-7.
13. Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology 2002, 122(7):1721-1728. 10.1053/gast.2002.33660, 12055576.
14. Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 2007, 46(2):297-306. 10.1002/hep.21695, 17461418.
15. Marcolongo M, Young B, Dal Pero F, Fattovich G, Peraro L, Guido M, Sebastiani G, Palu G, Alberti A. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology 2009, 50(4):1038-1044. 10.1002/hep.23111, 19676127.
16. Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, Kullak-Ublick GA, Meier PJ, Pauli-Magnus C. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics 2007, 17(1):47-60. 10.1097/01.fpc.0000230418.28091.76, 17264802.
17. Dixon PH, van Mil SW, Chambers J, Strautnieks S, Thompson RJ, Lammert F, Kubitz R, Keitel V, Glantz A, Mattsson LA, et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009, 58(4):537-544. 10.1136/gut.2008.159541, 18987030.
18. Meier Y, Zodan T, Lang C, Zimmermann R, Kullak-Ublick GA, Meier PJ, Stieger B, Pauli-Magnus C. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331 T > C polymorphism in the bile salt export pump. World J Gastroenterol 2008, 14(1):38-45. 10.3748/wjg.14.38, 2673389, 18176959.
19. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998, 273(16):10046-10050. 10.1074/jbc.273.16.10046, 9545351.
20. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998, 20(3):233-238. 10.1038/3034, 9806540.
21. Ho RH, Leake BF, Kilkenny DM, Meyer Zu Schwabedissen HE, Glaeser H, Kroetz DL, Kim RB. Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Pharmacogenet Genomics 2010, 20(1):45-57. 10.1097/FPC.0b013e3283349eb0, 2883163, 20010382.
22. Meier Y, Pauli-Magnus C, Zanger UM, Klein K, Schaeffeler E, Nussler AK, Nussler N, Eichelbaum M, Meier PJ, Stieger B. Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology 2006, 44(1):62-74.
23. Iwata R, Stieger B, Mertens JC, Muller T, Baur K, Frei P, Braun J, Vergopoulos A, Martin IV, Schmitt J, et al. The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C. J Viral Hepat 2011, 18(11):768-778. 10.1111/j.1365-2893.2010.01363.x, 20723035.
24. Iwata R, Baur K, Stieger B, Mertens JC, Daly AK, Frei P, Braun J, Vergopoulos A, Stickel F, Sabrane K, et al. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci (Lond) 2010, 120(7):287-296.
25. Krawczyk M, Grünhage F, Zimmer V, Lammert F. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. J Hepatol 2011, 55(2):299-306. 10.1016/j.jhep.2010.10.042, 21168459.
26. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008, 134(4):960-974. 10.1053/j.gastro.2008.01.034, 18395077.
27. Nojiri S, Nakao H, Sugauchi F, Miyaki T, Senda K, Sasaki M, Kataoka H, Kamiya T, Nakazawa T, Ohara H, et al. Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection. Hepatol Res 2009, 39(1):21-30. 10.1111/j.1872-034X.2008.00406.x, 18721155.
28. Omata M, Yoshida H, Toyota J, Tomita E, Nishiguchi S, Hayashi N, Iino S, Makino I, Okita K, Toda G, et al. A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C. Gut 2007, 56(12):1747-1753. 10.1136/gut.2007.120956, 2095694, 17573387.
29. Sato S, Miyake T, Tobita H, Oshima N, Ishine J, Hanaoka T, Amano Y, Kinoshita Y. A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients. World J Gastroenterol 2009, 15(22):2782-2786. 10.3748/wjg.15.2782, 2695895, 19522030.
30. Chang KO, George DW. Bile acids promote the expression of hepatitis C virus in replicon-harboring cells. J Virol 2007, 81(18):9633-9640. 10.1128/JVI.00795-07, 2045404, 17609266.
31. Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Thorne A, Nowak G, Ericzon BG, Bjorkhem I, Einarsson C. Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. Hepatology 2003, 38(4):930-938.
32. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000, 6(3):507-515. 10.1016/S1097-2765(00)00050-2, 11030331.
33. Scholtes C, Diaz O, Icard V, Kaul A, Bartenschlager R, Lotteau V, Andre P. Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR. J Hepatol 2008, 48(2):192-199. 10.1016/j.jhep.2007.09.015, 18096266.
34. Greenberg AS, Coleman RA, Kraemer FB, McManaman JL, Obin MS, Puri V, Yan QW, Miyoshi H, Mashek DG. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest 2011, 121(6):2102-2110. 10.1172/JCI46069, 3104768, 21633178.
35. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007, 9(9):1089-1097. 10.1038/ncb1631, 17721513.
36. Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 2008, 4(3):e1000035. 10.1371/journal.ppat.1000035, 2268006, 18369481.
37. Woodhouse SD, Narayan R, Latham S, Lee S, Antrobus R, Gangadharan B, Luo S, Schroth GP, Klenerman P, Zitzmann N. Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Hepatology 2010, 52(2):443-453. 10.1002/hep.23733, 3427885, 20683944.
38. Lu Y, Feskens EJ, Boer JM, Muller M. The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population. Atherosclerosis 2010, 210(1):14-27. 10.1016/j.atherosclerosis.2009.10.035, 19932478.
39. Henkel AS, Kavesh MH, Kriss MS, Dewey AM, Rinella ME, Green RM. Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice. Gastroenterology 2011, 141(4):1404-1411. 1411 e1401-1402, 10.1053/j.gastro.2011.06.062, 21726512.
40. Müllenbach R, Weber SN, Lammert F. Nuclear receptor variants in liver disease. J Lipids 2012, 2012:934707. 3317184, 22523693.